Utah Medical Products Inc (UTMD) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Utah Medical Products Inc  (NASDAQ: UTMD)
 

Utah Medical Products Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Utah Medical Products Inc's inventory turnover ratio sequentially decreased to 1.75 in the second quarter 2026, unsurprisingly, as the Utah Medical Products Inc markets continue to deteriorate, and UTMD's faces growing challenges to bring down its inventories. Utah Medical Products Inc's average inventory processing period in the Jun 30 2026 quarter, has increased to 209 days, from 201 days, in the Mar 31 2026 quarter.

Within Healthcare sector 227 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1621, from total ranking in the first quarter 2026 at 1714.

UTMD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Utah Medical Products Inc Market Share?

What is Inventory Turnover Ratio?




UTMD Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 9.35 % 0.86 % -9.95 % -10.86 % -9.11 %
Y / Y Cost of Sales Growth -5.73 % -25 % 4.3 % 0 % -3.54 %
Inventory Turnover Ratio (TTM) 1.75 1.82 1.94 1.87 1.82
UTMD's Total Ranking # 1621 # 1714 # 1649 # 1663 # 1681
Average inventory processing period 209 201 188 195 201
Seq. Inventory Growth 3.22 % 9.92 % -2.25 % -1.4 % -4.8 %
Seq. Cost of Sales Growth 25.7 % -25 % 0 % 0 % 0 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 99
Healthcare Sector # 228
Overall Market # 1621

Inventory Turnover Ratio Statistics
High Average Low
3.68 2.81 1.75
(Jun 30 2016)   (Jun 30 2026)




Financial Statements
Utah Medical Products Inc's Inventories $ 9 Millions Visit UTMD's Balance sheet
Utah Medical Products Inc's Cost of Revenues TTM $ 15 Millions Visit UTMD's Income Statement
What are UTMD's Sales? Visit UTMD's Sales by Segment

Other Inventory Turnover Ratios
Utah Medical Products Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
UTMD's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for UTMD's Competitors
Inventory Turnover Ratio for UTMD's Suppliers
Inventory Turnover Ratio for UTMD's Customers

You may also want to know
UTMD's Sales Growth Rates UTMD's Pe Price to earnings ratio UTMD's Receivables Turnover Ratio UTMD's Stock Quote
UTMD's Net Income Growth Rates UTMD's Ps Price to Sales ratio UTMD's Sales per Employee UTMD's Asset Turnover Ratio
UTMD's Net Margin UTMD's Pb Price to Book ratio UTMD's Financial Strength Ratios UTMD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions

Date modified: 2026-09-04T10:52:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.